Clinical Trial Update: Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 trial update on INS115644 ophthalmic solution in subjects with ocular hypertension or open-angle glaucoma; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• INS115644 ophthalmic solution (INS115644)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 1 | Status: COMPLETED